Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000902664-25-003768
Filing Date
2025-08-19
Accepted
2025-08-19 17:26:43
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 10800
2 JOINT FILING AGREEMENT p25-1880exhibit991.htm EX-99.1 5513
  Complete submission text file 0000902664-25-003768.txt   18045
Mailing Address 1200 PAGE MILL RD PALO ALTO CA 94304
Business Address 1200 PAGE MILL RD PALO ALTO CA 94304 650-281-0850
Kodiak Sciences Inc. (Subject) CIK: 0001468748 (see all company filings)

EIN.: 270476525 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-90673 | Film No.: 251233076
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 72 CUMMINGS POINT ROAD STAMFORD CT 06902
Business Address 72 CUMMINGS POINT ROAD STAMFORD CT 06902 203-890-2000
Point72 Asset Management, L.P. (Filed by) CIK: 0001603466 (see all company filings)

EIN.: 465064661 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G